Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.42	14.94	21.39	16.31	14.41	21.3
Cash & Short-Term Investments	17.42	14.94	21.39	16.31	14.41	21.3
Cash Growth	4.59%	-30.17%	31.17%	13.18%	-32.35%	76.49%
Receivables	16.4	5.36	3.41	1.85	5.47	0.05
Inventory	13.62	15.23	0.91	0.56	0.55	1.24
Prepaid Expenses	2.52	5.49	1.13	1.29	3.18	2.12
Total Current Assets	49.96	41.02	26.84	20	23.6	24.7
Property, Plant & Equipment	0.18	0.21	0.15	0.26	0.22	1
Other Intangible Assets	33.88	34.88	4.74	4.75	3.62	0.58
Other Long-Term Assets	0.01	0.01	0.01	0.01	0.02	0.04
Total Assets	84.03	76.12	31.74	25.03	27.47	26.32
Accounts Payable	4.87	4.17	1.85	1.77	1.77	2.34
Accrued Expenses	20.48	15.7	8.96	3.66	1.37	1.17
Current Portion of Long-Term Debt	-	-	5.38	1.03	1.42	0.28
Current Portion of Leases	-	0.08	0.05	-	-	-
Total Current Liabilities	25.35	19.95	16.24	6.46	4.56	3.79
Long-Term Debt	29.99	29.81	-	5.38	5.26	6.76
Long-Term Leases	0.09	0.11	0.02	0.11	0.02	0.1
Other Long-Term Liabilities	4.15	1.83	-	-	-	-
Total Liabilities	59.58	51.7	16.26	11.95	9.84	10.66
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02
Additional Paid-In Capital	133.89	132.29	119.52	116.19	111.72	107.8
Retained Earnings	-109.47	-107.89	-104.07	-103.13	-94.11	-92.16
Total Common Equity	24.45	24.43	15.48	13.08	17.63	15.66
Shareholders' Equity	24.45	24.43	15.48	13.08	17.63	15.66
Total Liabilities & Equity	84.03	76.12	31.74	25.03	27.47	26.32
Total Debt	30.08	29.99	5.46	6.52	6.7	7.14
Net Cash (Debt)	-12.66	-15.06	15.93	9.78	7.71	14.15
Net Cash Growth	-	-	62.90%	26.85%	-45.52%	88.53%
Net Cash Per Share	-0.48	-0.58	0.62	0.39	0.31	0.67
Filing Date Shares Outstanding	26.82	26.82	25.69	25.46	24.63	24.41
Total Common Shares Outstanding	26.82	26.71	25.69	25.35	24.63	24.31
Working Capital	24.61	21.07	10.6	13.54	19.05	20.91
Book Value Per Share	0.91	0.91	0.60	0.52	0.72	0.64
Tangible Book Value	-9.43	-10.45	10.74	8.32	14.01	15.09
Tangible Book Value Per Share	-0.35	-0.39	0.42	0.33	0.57	0.62
Machinery	-	0.38	0.35	0.34	0.4	1.32
Construction In Progress	-	-	-	0.01	-	-
Leasehold Improvements	-	0.1	0.1	0.07	0.07	0.18

Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q